Fundamental Analysis of HUMANIGEN INC(NASDAQ:HGEN) stock

Fundamental Rating

Overall HGEN gets a fundamental rating of 1 out of 10. We evaluated HGEN against 588 industry peers in the Biotechnology industry. HGEN has a bad profitability rating. Also its financial health evaluation is rather negative. HGEN is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year HGEN has reported negative net income.

HGEN had a negative operating cash flow in the past year.

HGEN had negative earnings in each of the past 5 years.

HGEN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The profitability ratios for HGEN are negative, so there is not much use analyzing them.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

HGEN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, HGEN has more shares outstanding

Compared to 5 years ago, HGEN has more shares outstanding

HGEN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -232.21, we must say that HGEN is in the distress zone and has some risk of bankruptcy.

HGEN has a Altman-Z score of -232.21. This is amonst the worse of the industry: HGEN underperforms 99.83% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-232.21

ROIC/WACCN/A

WACC11.19%

2.3 Liquidity

HGEN has a Current Ratio of 0.09. This is a bad value and indicates that HGEN is not financially healthy enough and could expect problems in meeting its short term obligations.

HGEN has a worse Current ratio (0.09) than 99.66% of its industry peers.

A Quick Ratio of 0.09 indicates that HGEN may have some problems paying its short term obligations.

HGEN's Quick ratio of 0.09 is on the low side compared to the rest of the industry. HGEN is outperformed by 99.66% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.09
Quick Ratio	0.09

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HGEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.50%, which is quite impressive.

HGEN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -59.01%.

EPS 1Y (TTM)79.5%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q87.5%

Revenue 1Y (TTM)-59.01%

Revenue growth 3YN/A

Revenue growth 5YN/A

Revenue growth Q2Q-78.67%

3.2 Future

The Earnings Per Share is expected to grow by 15.74% on average over the next years. This is quite good.

The Revenue is expected to grow by 110.13% on average over the next years. This is a very strong growth

EPS Next Y83.55%

EPS Next 2Y37.89%

EPS Next 3Y27.81%

EPS Next 5Y15.74%

Revenue Next Year-91.42%

Revenue Next 2Y-41.42%

Revenue Next 3Y165.44%

Revenue Next 5Y110.13%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

HGEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year HGEN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as HGEN's earnings are expected to grow with 27.81% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y37.89%

EPS Next 3Y27.81%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

HGEN does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HUMANIGEN INC

NASDAQ:HGEN (7/25/2023, 7:00:02 PM)

After market: 0.0358 0 (-0.83%)

0.0361

-0.16 (-81.12%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap4.30M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.33

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.09
Quick Ratio	0.09
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)79.5%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y83.55%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-59.01%

Revenue growth 3YN/A

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

HUMANIGEN INC (HGEN)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens